Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
OCFT
13551
CALL
DELISTED
OneConnect Financial Technology
OCFT
| $10.7K | ﹤0.01% |
4,400
-1,500
| -25% | -$3.88K |
2024 Q2
2 quarters
|
|
|
AZI
13552
Autozi Internet Technology
AZI
$75.6M
| $10.7K | ﹤0.01% |
26
-147
| -85% | -$90.3K |
2024 Q3
1 quarter
|
|
13553
CALL
Clarivate
CLVT
$928M
| $10.7K | ﹤0.01% |
2,100
-700
| -25% | -$4.03K |
2019 Q4
20 quarters
|
|
13554
CALL
Gerdau
GGB
$10.1B
| $10.7K | ﹤0.01% |
3,700
-14,100
| -79% | -$46.5K |
2019 Q2
22 quarters
|
|
13555
CALL
Xtrackers S&P 500 ESG ETF
SNPE
$2.85B
| $10.7K | ﹤0.01% |
200
-1,900
| -90% | -$102K |
2024 Q2
2 quarters
|
|
13556
PUT
Enlivex Ltd
ENLV
$7.21M
| $10.6K | ﹤0.01% |
607
+407
| +204% | +$7.92K |
2024 Q1
3 quarters
|
|
|
DMN
13557
DELISTED
Damon Inc. Common Stock
DMN
| $10.6K | ﹤0.01% |
+12,498
| New | +$12.2K |
2024 Q4
0 quarters
|
|
13558
CALL
NRC Health Common Stock
NRC
$460M
| $10.6K | ﹤0.01% |
600
+300
| +100% | +$5.69K |
2024 Q2
2 quarters
|
|
|
JZ
13559
Jianzhi Education Technology Group
JZ
$1.13M
| $10.6K | ﹤0.01% |
+39
| New | +$11.8K |
2024 Q4
0 quarters
|
|
|
PROF
13560
PUT
Profound Medical
PROF
$220M
| $10.5K | ﹤0.01% |
1,400
-3,600
| -72% | -$27.6K |
2024 Q3
1 quarter
|
|
|
NMG
13561
CALL
Nouveau Monde Graphite
NMG
$375M
| $10.5K | ﹤0.01% |
+6,600
| New | +$9.5K |
2024 Q4
0 quarters
|
|
13562
PUT
Kyverna Therapeutics
KYTX
$391M
| $10.5K | ﹤0.01% |
2,800
-11,000
| -80% | -$52.7K |
2024 Q1
3 quarters
|
|
13563
CALL
Healthcare Services Group
HCSG
$1.45B
| $10.5K | ﹤0.01% |
900
-9,900
| -92% | -$113K |
2022 Q4
8 quarters
|
|
13564
Full House Resorts
FLL
$50.2M
| $10.4K | ﹤0.01% |
2,555
-46,183
| -95% | -$218K |
2022 Q4
8 quarters
|
|
13565
PUT
Nomura Holdings
NMR
$28.5B
| $10.4K | ﹤0.01% |
1,800
-1,100
| -38% | -$6.24K |
2023 Q3
5 quarters
|
|
13566
CALL
Clarus
CLAR
$132M
| $10.4K | ﹤0.01% |
2,300
-300
| -12% | -$1.35K |
2022 Q2
10 quarters
|
|
13567
PUT
Puma Biotechnology
PBYI
$499M
| $10.4K | ﹤0.01% |
3,400
-300
| -8% | -$873 |
2022 Q3
9 quarters
|
|
|
MLNK
13568
PUT
DELISTED
MeridianLink
MLNK
| $10.3K | ﹤0.01% |
500
+100
| +25% | +$2.2K |
2023 Q4
4 quarters
|
|
|
PFC
13569
CALL
DELISTED
Premier Financial Corp. Common Stock
PFC
| $10.2K | ﹤0.01% |
+400
| New | +$10.4K |
2024 Q4
0 quarters
|
|
|
YI
13570
CALL
111 Inc
YI
$27.7M
| $10.2K | ﹤0.01% |
1,640
+180
| +12% | +$1.4K |
2024 Q2
2 quarters
|
|
13571
Aterian
ATER
$11.4M
| $10.2K | ﹤0.01% |
4,251
-7,876
| -65% | -$20.9K |
2024 Q2
2 quarters
|
|
13572
PUT
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$572M
| $10.2K | ﹤0.01% |
300
-4,700
| -94% | -$162K |
2021 Q1
15 quarters
|
|
13573
CALL
StealthGas
GASS
$344M
| $10.2K | ﹤0.01% |
1,800
-26,700
| -94% | -$156K |
2021 Q1
15 quarters
|
|
13574
CALL
Cellectar Biosciences
CLRB
$15.8M
| $10.2K | ﹤0.01% |
1,133
+10
| +0.9% | +$462 |
2024 Q1
3 quarters
|
|
13575
CALL
ADC Therapeutics
ADCT
$157M
| $10.1K | ﹤0.01% |
5,100
-3,900
| -43% | -$10.2K |
2024 Q1
3 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.